S. Willot

680 total citations
17 papers, 393 citations indexed

About

S. Willot is a scholar working on Genetics, Surgery and Rheumatology. According to data from OpenAlex, S. Willot has authored 17 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Surgery and 5 papers in Rheumatology. Recurrent topics in S. Willot's work include Inflammatory Bowel Disease (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). S. Willot is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). S. Willot collaborates with scholars based in France, Canada and Switzerland. S. Willot's co-authors include Gilles Paintaud, David Ternant, Denis Mulleman, Philippe Goupille, Hervé Watier, Angela Noble, Colette Deslandres, Danielle Degenne, Jean-Maurice Guillaumin and Christophe Fauré and has published in prestigious journals such as PEDIATRICS, Clinical Pharmacokinetics and Inflammatory Bowel Diseases.

In The Last Decade

S. Willot

17 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Willot France	11	165	114	112	103	64	17	393
Maria Weidinger Germany	9	272 1.6×	80 0.7×	138 1.2×	162 1.6×	66 1.0×	15	408
Ravishankar Sargur United Kingdom	12	64 0.4×	72 0.6×	89 0.8×	51 0.5×	60 0.9×	26	379
Arnold Stronkhorst Netherlands	9	157 1.0×	100 0.9×	77 0.7×	91 0.9×	20 0.3×	22	310
Eunice Trindade Portugal	11	114 0.7×	245 2.1×	83 0.7×	96 0.9×	116 1.8×	47	411
Chenxiong Le United States	8	46 0.3×	63 0.6×	175 1.6×	148 1.4×	87 1.4×	11	512
A M van der Wal Netherlands	10	138 0.8×	112 1.0×	65 0.6×	84 0.8×	19 0.3×	13	336
Guðmundur H. Jörgensen Iceland	8	125 0.8×	36 0.3×	325 2.9×	34 0.3×	37 0.6×	8	397
Dhiman Basu United States	5	138 0.8×	58 0.5×	77 0.7×	157 1.5×	55 0.9×	7	304
Gregor Novak Slovenia	14	376 2.3×	118 1.0×	138 1.2×	289 2.8×	16 0.3×	27	495
Philip Ginsburg United States	9	110 0.7×	136 1.2×	24 0.2×	140 1.4×	71 1.1×	17	337

Countries citing papers authored by S. Willot

Since Specialization

Citations

This map shows the geographic impact of S. Willot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Willot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Willot more than expected).

Fields of papers citing papers by S. Willot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Willot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Willot. The network helps show where S. Willot may publish in the future.

Co-authorship network of co-authors of S. Willot

This figure shows the co-authorship network connecting the top 25 collaborators of S. Willot. A scholar is included among the top collaborators of S. Willot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Willot. S. Willot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ternant, David, Marc Pfister, Denis Mulleman, et al.. (2021). Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model. Clinical Pharmacokinetics. 61(1). 143–154. 7 indexed citations

Tavernier, Elsa, L. Brunereau, Fanny Dujardin, et al.. (2021). Liver shear wave elastography and attenuation imaging coefficient measures: prospective evaluation in healthy children. Abdominal Radiology. 46(10). 4629–4636. 10 indexed citations

Petitcollin, Antoine, Camille Tron, F. Lemaı̂tre, et al.. (2018). Modeling Immunization To Infliximab in Children With Crohn’s Disease Using Population Pharmacokinetics: A Pilot Study. Inflammatory Bowel Diseases. 24(8). 1745–1754. 21 indexed citations

Bodemer, Christine, G. Lorette, Sylvie Fraitag, et al.. (2016). Exocrine pancreatic insufficiency in a child with Netherton syndrome. European Journal of Dermatology. 26(3). 311–312. 3 indexed citations

Passot, Christophe, Denis Mulleman, Théodora Bejan‐Angoulvant, et al.. (2016). The underlying inflammatory chronic disease influences infliximab pharmacokinetics. mAbs. 8(7). 1407–1416. 54 indexed citations

Pélatan, C., S. Willot, Jean‐Louis Giniès, et al.. (2015). Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection. Digestive and Liver Disease. 47(6). 460–464. 13 indexed citations

Hubert, G., et al.. (2014). Shunts porto-systémiques congénitaux : expérience du Grand-Ouest sur cinq ans. Archives de Pédiatrie. 21(11). 1187–1194. 6 indexed citations

Willot, S., Jean‐Louis Giniès, C. Pélatan, et al.. (2013). Immunization status in children with inflammatory bowel disease. European Journal of Pediatrics. 173(5). 603–8. 12 indexed citations

Willot, S., Cindy Gauthier, Natalie Patey, & Christophe Fauré. (2012). Nerve growth factor content is increased in the rectal mucosa of children with diarrhea‐predominant irritable bowel syndrome. Neurogastroenterology & Motility. 24(8). 734–734. 41 indexed citations

10.

Willot, S., et al.. (2011). Esophageal squamous papilloma in children. Endoscopy. 43(S 02). E256–E256. 1 indexed citations

11.

Willot, S., Angela Noble, & Colette Deslandres. (2011). Methotrexate in the treatment of inflammatory bowel disease: An 8-year retrospective study in a Canadian pediatric IBD center. Inflammatory Bowel Diseases. 17(12). 2521–2526. 36 indexed citations

12.

Labarthe, F., et al.. (2010). Nutrition des maladies métaboliques rares en pédiatrie. Réanimation. 19(5). 441–447. 1 indexed citations

13.

Willot, S., Valérie Marchand, Andrée Rasquin, Fernando Álvarez, & Steven R. Martin. (2010). Systemic Progression of Type IV Glycogen Storage Disease After Liver Transplantation. Journal of Pediatric Gastroenterology and Nutrition. 51(5). 661–664. 13 indexed citations

14.

Willot, S., et al.. (2008). Prolapsus rectal chez un enfant de 3 ans 8 mois. Archives de Pédiatrie. 15(9). 1437–1439. 4 indexed citations

15.

Willot, S., S Uhlen, L. Michaud, et al.. (2008). Effect of Ursodeoxycholic Acid on Liver Function in Children After Successful Surgery for Biliary Atresia. PEDIATRICS. 122(6). e1236–e1241. 48 indexed citations

16.

Willot, S., Séverine Vermeire, Marc Ohresser, et al.. (2006). No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease. Pharmacogenetics and Genomics. 16(1). 37–42. 37 indexed citations

17.

Ternant, David, Denis Mulleman, Danielle Degenne, et al.. (2006). An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Infliximab. Therapeutic Drug Monitoring. 28(2). 169–174. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact